Investigative Ophthalmology & Visual Science Cover Image for Volume 61, Issue 7
June 2020
Volume 61, Issue 7
Free
ARVO Annual Meeting Abstract  |   June 2020
Comparative Assessment of a Machine Learning-Enhanced Layer Segmentation Platform to Conventional Image Processing Segmentation for Spectral Domain OCT in Retinal Diseases.
Author Affiliations & Notes
  • Chukwumamkpam Uzoegwu
    Ophthalmology, Cole Eye Institute, Cleveland, Ohio, United States
    School of Medicine, Case Western Reserve University, Cleveland, Ohio, United States
  • Joseph R Abraham
    Ophthalmology, Cole Eye Institute, Cleveland, Ohio, United States
  • Jenna M Hach
    Ophthalmology, Cole Eye Institute, Cleveland, Ohio, United States
  • Sunil K Srivastava
    Ophthalmology, Cole Eye Institute, Cleveland, Ohio, United States
  • Thuy Le
    Ophthalmology, Cole Eye Institute, Cleveland, Ohio, United States
  • Leina Lunasco
    Ophthalmology, Cole Eye Institute, Cleveland, Ohio, United States
  • Jon Whitney
    ERT, Ohio, United States
  • Amit Vasanji
    ERT, Ohio, United States
  • Jamie Reese
    Ophthalmology, Cole Eye Institute, Cleveland, Ohio, United States
  • Justis P Ehlers
    Ophthalmology, Cole Eye Institute, Cleveland, Ohio, United States
  • Footnotes
    Commercial Relationships   Chukwumamkpam Uzoegwu, None; Joseph Abraham, None; Jenna Hach, None; Sunil Srivastava, Allergan (F), Bausch and Lomb (C), Gilead (F), Leica (P), Regeneron (F), Santen (C); Thuy Le, None; Leina Lunasco, None; Jon Whitney, ERT (E); Amit Vasanji, ERT (E); Jamie Reese, None; Justis Ehlers, Aerpio (F), Aerpio (C), Alcon (F), Alcon (C), Allegro (C), Allergan (F), Allergan (C), Genentech (F), Genentech/Roche (C), Leica (C), Leica (P), Novartis (F), Novartis (C), Regeneron (F), Regeneron (C), Santen (C), Thrombogenics/Oxurion (F), Thrombogenics/Oxurion (C), Zeiss (C)
  • Footnotes
    Support  RPB Unrestricted Grant to the Cole Eye Institute RPB1508DM; NIH K23 -EY022947
Investigative Ophthalmology & Visual Science June 2020, Vol.61, 904. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Chukwumamkpam Uzoegwu, Joseph R Abraham, Jenna M Hach, Sunil K Srivastava, Thuy Le, Leina Lunasco, Jon Whitney, Amit Vasanji, Jamie Reese, Justis P Ehlers; Comparative Assessment of a Machine Learning-Enhanced Layer Segmentation Platform to Conventional Image Processing Segmentation for Spectral Domain OCT in Retinal Diseases.. Invest. Ophthalmol. Vis. Sci. 2020;61(7):904.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : Optimizing efficiency and accuracy of layer segmentation is important for rapid disease assessment and improving disease understanding. This study examined the comparative performance of a 1st generation Enhanced Deep Neural Network Algorithm (EDNA) in quantifying retinal layers in an automated fashion in eyes with age-related macular degeneration (AMD), Plaquenil exposure (PLAQ), diabetic macular edema (DME), and eyes without retinal disease (NL) to expert reader (ER)-corrected segmentation and a logic based algorithm (LBA).

Methods : In this image analysis study, 80 NS eyes, 40 AMD eyes, 80 PLAQ eyes, and 77 DME eyes were included. The gold standard metrics for this analysis was based on ER-corrected segmentation scans originally assessed with the LBA. EDNA was developed as an enhancement to the previously described LBA to improve accuracy and efficiency. For this analysis, the inner limiting membrane (ILM) and retinal pigment epithelium (RPE) were segmented. The intraclass correlation coefficients (ICC) for EDNA and the LBA were calculated by comparing their respective segmentation metrics for central subfield thickness (CST) to the ER metrics, and categorized using Cicchetti’s criteria (<0.4 = poor, 0.4 – 0.59 = fair, 0.6 – 0.74 = good, 0.75 – 1.00 = excellent).

Results : EDNA demonstrated good to excellent correlation performance when compared to ER in all disease categories for assessment of retinal thickness (i.e., ILM to RPE). EDNA performance demonstrated higher correlation with ER than the LBA in AMD and PLAQ (ICC CST: 0.60 vs 0.45 ; 0.88 vs 0.61). EDNA also demonstrated similar correlation compared to the LBA when measuring mean retinal thickness in NL (ICC CST: 0.88 vs 0.97). In eyes with DME, EDNA demonstrated a slightly lower correlation to ER than LBA (ICC CST: 0.65 vs 0.81).

Conclusions : EDNA demonstrated good-to-excellent correlation to ER-corrected segmentation across multiple retinal diseases. The next generation EDNA system is currently under development and will be explored for enhanced multi-layer performance while minimizing the requirement for human reader intervention.

This is a 2020 ARVO Annual Meeting abstract.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×